China High Potency Active Pharmaceutical Ingredient Market Research Report 2016

November 2016 | 102 pages | ID: C58F7FF80BFEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of High Potency Active Pharmaceutical Ingredient

Revenue, means the sales value of High Potency Active Pharmaceutical Ingredient

This report studies High Potency Active Pharmaceutical Ingredient in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering

• Alkermes
• Cambex
• Dr. Reddy’s Labotatories
• Lonza Group
• Novasep
• Sandoz

Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Synthetic
• Biotech
• Type III

Split by Application, this report focuses on consumption, market share and growth rate of High Potency Active Pharmaceutical Ingredient in each application, can be divided into

• Oncology
• Hormonal disorders
• Glaucoma
• Others

Contents

China High Potency Active Pharmaceutical Ingredient Market Research Report 2016

1 HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT MARKET OVERVIEW

1.1 Product Overview and Scope of High Potency Active Pharmaceutical Ingredient
1.2 High Potency Active Pharmaceutical Ingredient Segment by Type
  1.2.1 China Production Market Share of High Potency Active Pharmaceutical Ingredient Type in 2015
  1.2.2 Synthetic
  1.2.3 Biotech
  1.2.4 Type III
1.3 Applications of High Potency Active Pharmaceutical Ingredient
  1.3.1 High Potency Active Pharmaceutical Ingredient Consumption Market Share by Application in 2015
  1.3.2 Oncology
  1.3.3 Hormonal disorders
  1.3.4 Glaucoma
  1.3.5 Others
1.4 China Market Size (Value) of High Potency Active Pharmaceutical Ingredient (2011-2021)
1.5 China High Potency Active Pharmaceutical IngredientStatus and Outlook
1.6 Government Policies

2 CHINA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT MARKET COMPETITION BY MANUFACTURERS

2.1 China High Potency Active Pharmaceutical Ingredient Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China High Potency Active Pharmaceutical Ingredient Revenue and Share by Manufacturers (2015 and 2016)
2.3 China High Potency Active Pharmaceutical Ingredient Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers High Potency Active Pharmaceutical Ingredient Manufacturing Base Distribution, Sales Area, Product Type
2.5 High Potency Active Pharmaceutical Ingredient Market Competitive Situation and Trends
  2.5.1 High Potency Active Pharmaceutical Ingredient Market Concentration Rate
  2.5.2 High Potency Active Pharmaceutical Ingredient Market Share of Top 3 and Top 5 Manufacturers

3 CHINA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT MANUFACTURERS PROFILES/ANALYSIS

3.1 Alkermes
  3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.1.2 High Potency Active Pharmaceutical Ingredient Product Type, Application and Specification
    3.1.2.1 Type I
    3.1.2.2 Type II
  3.1.3 Alkermes High Potency Active Pharmaceutical Ingredient Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.1.4 Main Business/Business Overview
3.2 Cambex
  3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.2.2 102 Product Type, Application and Specification
    3.2.2.1 Type I
    3.2.2.2 Type II
  3.2.3 Cambex 102 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.2.4 Main Business/Business Overview
3.3 Dr. Reddy’s Labotatories
  3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.3.2 111 Product Type, Application and Specification
    3.3.2.1 Type I
    3.3.2.2 Type II
  3.3.3 Dr. Reddy’s Labotatories 111 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.3.4 Main Business/Business Overview
3.4 Lonza Group
  3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.4.2 Nov Product Type, Application and Specification
    3.4.2.1 Type I
    3.4.2.2 Type II
  3.4.3 Lonza Group Nov Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.4.4 Main Business/Business Overview
3.5 Novasep
  3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.5.2 Product Type, Application and Specification
    3.5.2.1 Type I
    3.5.2.2 Type II
  3.5.3 Novasep Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.5.4 Main Business/Business Overview
3.6 Sandoz
  3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.6.2 Million USD Product Type, Application and Specification
    3.6.2.1 Type I
    3.6.2.2 Type II
  3.6.3 Sandoz Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.6.4 Main Business/Business Overview

4 CHINA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2011-2016)

4.1 China High Potency Active Pharmaceutical Ingredient Capacity, Production and Growth (2011-2016)
4.2 China High Potency Active Pharmaceutical Ingredient Revenue and Growth (2011-2016)
4.3 China High Potency Active Pharmaceutical Ingredient Production, Consumption, Export and Import (2011-2016)

5 CHINA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China High Potency Active Pharmaceutical Ingredient Production and Market Share by Type (2011-2016)
5.2 China High Potency Active Pharmaceutical Ingredient Revenue and Market Share by Type (2011-2016)
5.3 China High Potency Active Pharmaceutical Ingredient Price by Type (2011-2016)
5.4 China High Potency Active Pharmaceutical Ingredient Production Growth by Type (2011-2016)

6 CHINA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT MARKET ANALYSIS BY APPLICATION

6.1 China High Potency Active Pharmaceutical Ingredient Consumption and Market Share by Application (2011-2016)
6.2 China High Potency Active Pharmaceutical Ingredient Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Application
  6.3.2 Emerging Markets/Countries

7 HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT MANUFACTURING COST ANALYSIS

7.1 High Potency Active Pharmaceutical Ingredient Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of High Potency Active Pharmaceutical Ingredient

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 High Potency Active Pharmaceutical Ingredient Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of High Potency Active Pharmaceutical Ingredient Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT MARKET FORECAST (2016-2021)

11.1 China High Potency Active Pharmaceutical Ingredient Capacity, Production, Revenue Forecast (2016-2021)
11.2 China High Potency Active Pharmaceutical Ingredient Production, Import, Export and Consumption Forecast (2016-2021)
11.3 China High Potency Active Pharmaceutical Ingredient Production Forecast by Type (2016-2021)
11.4 China High Potency Active Pharmaceutical Ingredient Consumption Forecast by Application (2016-2021)
11.5 High Potency Active Pharmaceutical Ingredient Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of High Potency Active Pharmaceutical Ingredient
Figure China Production Market Share of High Potency Active Pharmaceutical Ingredient by Type in 2015
Figure Product Picture of Synthetic
Table Major Manufacturers of Synthetic
Figure Product Picture of Biotech
Table Major Manufacturers of Biotech
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table High Potency Active Pharmaceutical Ingredient Consumption Market Share by Application in 2015
Figure Oncology Examples
Figure Hormonal disorders Examples
Figure Glaucoma Examples
Figure Others Examples
Figure China High Potency Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2011-2021)
Table China High Potency Active Pharmaceutical Ingredient Capacity of Key Manufacturers (2015 and 2016)
Table China High Potency Active Pharmaceutical Ingredient Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China High Potency Active Pharmaceutical Ingredient Capacity of Key Manufacturers in 2015
Figure China High Potency Active Pharmaceutical Ingredient Capacity of Key Manufacturers in 2016
Table China High Potency Active Pharmaceutical Ingredient Production of Key Manufacturers (2015 and 2016)
Table China High Potency Active Pharmaceutical Ingredient Production Share by Manufacturers (2015 and 2016)
Figure 2015 High Potency Active Pharmaceutical Ingredient Production Share by Manufacturers
Figure 2016 High Potency Active Pharmaceutical Ingredient Production Share by Manufacturers
Table China High Potency Active Pharmaceutical Ingredient Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China High Potency Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China High Potency Active Pharmaceutical Ingredient Revenue Share by Manufacturers
Table 2016 China High Potency Active Pharmaceutical Ingredient Revenue Share by Manufacturers
Table China Market High Potency Active Pharmaceutical Ingredient Average Price of Key Manufacturers (2015 and 2016)
Figure China Market High Potency Active Pharmaceutical Ingredient Average Price of Key Manufacturers in 2015
Table Manufacturers High Potency Active Pharmaceutical Ingredient Manufacturing Base Distribution and Sales Area
Table Manufacturers High Potency Active Pharmaceutical Ingredient Product Type
Figure High Potency Active Pharmaceutical Ingredient Market Share of Top 3 Manufacturers
Figure High Potency Active Pharmaceutical Ingredient Market Share of Top 5 Manufacturers
Table Alkermes Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alkermes High Potency Active Pharmaceutical Ingredient Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Alkermes High Potency Active Pharmaceutical Ingredient Market Share (2011-2016)
Table Cambex Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cambex High Potency Active Pharmaceutical Ingredient Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Cambex High Potency Active Pharmaceutical Ingredient Market Share (2011-2016)
Table Dr. Reddy’s Labotatories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dr. Reddy’s Labotatories High Potency Active Pharmaceutical Ingredient Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Dr. Reddy’s Labotatories High Potency Active Pharmaceutical Ingredient Market Share (2011-2016)
Table Lonza Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lonza Group High Potency Active Pharmaceutical Ingredient Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Lonza Group High Potency Active Pharmaceutical Ingredient Market Share (2011-2016)
Table Novasep Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novasep High Potency Active Pharmaceutical Ingredient Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novasep High Potency Active Pharmaceutical Ingredient Market Share (2011-2016)
Table Sandoz Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sandoz High Potency Active Pharmaceutical Ingredient Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Sandoz High Potency Active Pharmaceutical Ingredient Market Share (2011-2016)
Figure China High Potency Active Pharmaceutical Ingredient Capacity, Production and Growth (2011-2016)
Figure China High Potency Active Pharmaceutical Ingredient Revenue (Million USD) and Growth (2011-2016)
Table China High Potency Active Pharmaceutical Ingredient Production, Consumption, Export and Import (2011-2016)
Table China High Potency Active Pharmaceutical Ingredient Production by Type (2011-2016)
Table China High Potency Active Pharmaceutical Ingredient Production Share by Type (2011-2016)
Figure Production Market Share of High Potency Active Pharmaceutical Ingredient by Type (2011-2016)
Figure 2015 Production Market Share of High Potency Active Pharmaceutical Ingredient by Type
Table China High Potency Active Pharmaceutical Ingredient Revenue by Type (2011-2016)
Table China High Potency Active Pharmaceutical Ingredient Revenue Share by Type (2011-2016)
Figure Production Revenue Share of High Potency Active Pharmaceutical Ingredient by Type (2011-2016)
Figure 2015 Revenue Market Share of High Potency Active Pharmaceutical Ingredient by Type
Table China High Potency Active Pharmaceutical Ingredient Price by Type (2011-2016)
Figure China High Potency Active Pharmaceutical Ingredient Production Growth by Type (2011-2016)
Table China High Potency Active Pharmaceutical Ingredient Consumption by Application (2011-2016)
Table China High Potency Active Pharmaceutical Ingredient Consumption Market Share by Application (2011-2016)
Figure China High Potency Active Pharmaceutical Ingredient Consumption Market Share by Application in 2015
Table China High Potency Active Pharmaceutical Ingredient Consumption Growth Rate by Application (2011-2016)
Figure China High Potency Active Pharmaceutical Ingredient Consumption Growth Rate by Application (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of High Potency Active Pharmaceutical Ingredient
Figure Manufacturing Process Analysis of High Potency Active Pharmaceutical Ingredient
Figure High Potency Active Pharmaceutical Ingredient Industrial Chain Analysis
Table Raw Materials Sources of High Potency Active Pharmaceutical Ingredient Major Manufacturers in 2015
Table Major Buyers of High Potency Active Pharmaceutical Ingredient
Table Distributors/Traders List
Figure China High Potency Active Pharmaceutical Ingredient Capacity, Production and Growth Rate Forecast (2016-2021)
Figure China High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate Forecast (2016-2021)
Table China High Potency Active Pharmaceutical Ingredient Production, Import, Export and Consumption Forecast (2016-2021)
Table China High Potency Active Pharmaceutical Ingredient Production Forecast by Type (2016-2021)
Table China High Potency Active Pharmaceutical Ingredient Consumption Forecast by Application (2016-2021)